---
title: "Context appoints Raja H. R. Bobbili and David Abrams to Board"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277105108.md"
description: "Context has appointed Raja H. R. Bobbili and David Abrams as Directors to its Board, effective February 20, 2026. This appointment is in accordance with the Purchase Agreement. Raja H. R. Bobbili is the Managing Director at Abrams Capital and has a strong academic background, while David Abrams is the Founder and CEO of Abrams Capital, with previous experience at The Baupost Group. Further details regarding their roles or replacements were not disclosed."
datetime: "2026-02-26T22:03:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277105108.md)
  - [en](https://longbridge.com/en/news/277105108.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277105108.md)
---

# Context appoints Raja H. R. Bobbili and David Abrams to Board

**Context appointed Raja H. R. Bobbili and David Abrams to its Board, effective February 20, 2026.**

Individual

Raja H. R. Bobbili

David Abrams

Role

Director (Board appointee)

Director (Board appointee)

Type of Change

Appointed

Appointed

Effective Date

February 20, 2026

February 20, 2026

Reason

Appointment as contemplated by the Purchase Agreement

Appointment as contemplated by the Purchase Agreement

Replacement Info

Not disclosed

Not disclosed

Background Details

Managing Director at Abrams Capital; serves on corporate and non-profit boards; MIT undergrad; J.D./M.B.A. from Harvard

Founder, CEO and Portfolio Manager of Abrams Capital since 1999; former senior investment professional at The Baupost Group; B.A., University of Pennsylvania

Board/Committee Role Changes

Not disclosed

Not disclosed

Original SEC Filing: ContextLogic Holdings Inc. \[ LOGC \] - 8-K - Feb. 26, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CNTX.US](https://longbridge.com/en/quote/CNTX.US.md)

## Related News & Research

- [Context Therapeutics Pays $6.5 Million to Make BioAtla Antibody Licenses Perpetual and Royalty-Free](https://longbridge.com/en/news/286758291.md)
- [Do Billionaires Chase Coleman and David Tepper Know Something About UnitedHealth Stock That Wall Street Doesn't?](https://longbridge.com/en/news/287745916.md)
- [A Look At Thermo Fisher Scientific (TMO) Valuation After Investor Day, Sweden Lab Opening And Dividend Reaffirmation](https://longbridge.com/en/news/287510880.md)
- [David P. King elected to Illumina's Board of Directors | ILMN Stock News](https://longbridge.com/en/news/287267671.md)
- [Medpace Holdings, Inc. $MEDP Shares Sold by Swedbank AB](https://longbridge.com/en/news/287746203.md)